Companies / Pandion Therapeutics, Inc.
Pandion Therapeutics, Inc.
PANDCIK 1807901
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 1, 2021 | Carroll Jill Director | Other Shares tendered | Common Stock | $340.45M | -5.7M -100.00% | 0 | low |
| Apr 1, 2021 | Crane Alan L Director | Other Shares tendered | Common Stock | $185.45M | -3.1M -100.00% | 0 | low |
| Apr 1, 2021 | Becker Daniel J. Director | Other Shares tendered | Common Stock | $169.67M | -2.8M -100.00% | 0 | low |
| Apr 1, 2021 | Fuglesang Christopher Director | Other Shares tendered | Common Stock | $126.45M | -2.1M -100.00% | 0 | low |
| Apr 1, 2021 | Kakkar Rahul CEO | Other Shares tendered | Common Stock | $42.15M | -703K -100.00% | 0 | low |
| Apr 1, 2021 | Viney Joanne L. Executive | Other Shares tendered | Common Stock | $30.20M | -503K -100.00% | 0 | low |
| Apr 1, 2021 | Crane Alan L Director | Other Shares tendered | Common Stock | $20.18M | -336K -100.00% | 0 | low |
| Apr 1, 2021 | Sundy John Executive | Other Shares tendered | Common Stock | $6.95M | -116K -100.00% | 0 | low |